Healthcare organizations expanding into emerging markets like Brazil, Russia, India and China (BRIC) are realizing there are no shortcuts.  This is proving particularly challenging, considering the current healthcare environment, especially in the United States.  Companies must change the dialogue a more

Evolving technologies and market forces reveal that digital pathology is poised to radically affect the daily workflow and activities of pathologists and diagnostic laboratories. Attracted by the prospect of improved connectivity and reduced overall healthcare costs, most laboratories are anticipate more

Government funding, growth and consolidation of the middle class, and the rise in non-communicable diseases will enable Turkey to remain one of the sought-after countries for healthcare investment. Turkey offers immense potential for companies across the healthcare spectrum, from healthcare technolo more

Original equipment manufacturers (OEMs) are increasingly turning to electronics manufacturing service (EMS) providers to better handle the escalating volumes of electronic content in the medical industry. With opportunities for high-level product assembly and complete build projects expected to incr more

Merck Serono announced that based on its recent analysis of the human growth hormones (HGH) market, Frost & Sullivan recognises Merck Serono with the 2013 Europe Product Differentiation Excellence Award. “Merck Serono is lauded for its cutting-edge drug delivery devices - easypod® and cool.click®2 – more

The need to improve the efficiency and quality of X-ray examinations will drive healthcare facilities across Europe to install computed radiography (CR) and digital radiography (DR) systems. The emergence of retrofit systems based on flat panel technology has popularised DR systems, and will sustain more

The European market for interventional radiology and cardiology is heading towards maturity, especially in Western Europe. Although the economic slowdown and fewer orders had a negative impact on revenues in 2012, it is expected that expanding applications of interventional systems and the popularis more

The limited efficacy and negative side-effects associated with current therapeutics for Hepatitis B and C are highlighting the urgent need for new, improved alternatives. Combination therapies offering better clinical outcomes are coming to the fore and look set to transform the European market for more

Image-guided and robot-assisted surgeries have made successful inroads into the western European market. The significant cost and clinical benefits offered by such advanced surgical systems has been key to boosting their adoption rates. New analysis from Frost & Sullivan, Image-guided and Robot-assi more

Remote patient monitoring (RPM) technologies help patients retain their independence and avert further health complications. These technologies can also be a vital tool for governments to curb spiralling healthcare expenditures. New analysis from Frost & Sullivan, European Market for Remote Patient more